Avreo and Annalise.ai partner to transform radiology triage

The companies join forces to transform the US radiology landscape with a focus on teleradiology

29th November Charleston, SC – Today, Avreo, a leading US healthcare workflow solution provider, announced an exciting partnership with Annalise.ai, a pioneer in artificial intelligence for medical imaging. This collaboration aims to revolutionize radiology triage for US healthcare centers through the distribution of Annalise.ai’s cutting-edge solution with a focus on teleradiology providers.

Avreo’s innovative interWORKS platform offers cloud-based access to workflow management, diagnostic viewing, and unified reporting tools that excel in distributed reading environments and seamlessly interoperate with enterprise healthcare systems.

Annalise triage is set to transform the radiology field by empowering radiologists to efficiently prioritize studies with suspected critical findings. This innovative solution streamlines workflow, supporting faster time-to-detect for urgent conditions.

“By embedding Annalise.ai’s powerful technology directly into the interWORKS worklist and diagnostic viewer, radiology groups can strategically manage imaging workflows with elevated confidence, improve rapid response reporting on critical exams, and deliver higher quality services to their clients and patients,” said Timothy Rose, VP Business Development at Avreo Inc.

Annalise Triage features an impressive selection of 12 FDA-cleared findings, encompassing 5 for chest X-ray (CXR) and 7 for non-contrast brain CT (CTB). This comprehensive offering has obtained the 510(k) clearances and also the FDA breakthrough designation for obstructive hydrocephalus. Annalise Triage stands as the sole radiology triage device to attain this recognition, exclusively awarded to devices meeting specific criteria*.

“The integration of Annalise Triage with Avreo’s suite of digital products enables streamlined diagnostic workflows for radiologists and will help guide providers to the most appropriate action at the ideal time to deliver the best possible patient care”, added Timothy.

“We are thrilled to join forces with Avreo to bring our triage solution to a wider audience,” said Lakshmi Gudapakkam, CEO at Annalise.ai. “The synergy between our AI-driven capabilities and Avreo’s industry-leading workflow solutions will undoubtedly make a positive impact on radiologists’ day-to-day operations.”

By incorporating Annalise.ai’s triage solution into Avreo’s comprehensive suite of healthcare workflow tools, radiologists can expect improved triaging and increased efficiency in managing high-priority cases. The collaboration aligns with both companies’ shared commitment to advancing patient care through innovative technologies.

For more information on the partnership visit https://www.avreo.com/ and https://annalise.ai/.

*FDA website as of March 2023

1 Breakthrough Devices Program | FDA These criteria include: enhancing the diagnosis or treatment of life-threatening or irreversibly debilitating conditions; introducing breakthrough technology; providing a significant advantage over existing alternatives; and prioritizing the well-being of patients

Annalise Triage is only available in the U.S. The device is intended for use by healthcare professionals only. The device is not intended to provide diagnosis. For detailed device information, including indications for use, contraindications, and warnings, please consult the user guide prior to use.

A comprehensive decision-support tool. Powered by AI. Visit Web demo